Searched for
BICON
Chinese warships go ballistic with new mystery missileThe new weapon is presumed by most commentators to be an anti-ship ballistic missile, which analysts refer to under the nomenclature of YJ-...- 6 pharma stocks to bet on amid Covid 2.0"The private market has opened up for vaccination and Dr Reddy’s is likely to benefit from the sale of Sputnik-V vaccine."
- IIT Guwahati researchers develop materials to produce energy from water on a small scaleAccording to IIT-Guwahati these new ways of producing energy can be employed in household environments to support the concept of decentrali...
- IIT Guwahati researchers develop materials to produce energy from water on a small scaleAccording to IIT-Guwahati these new ways of producing energy can be employed in household environments to support the concept of decentrali...
- Temasek, TrueNorth-CPPIB seek to invest in Biocon BiologicsEye minority stake in Biocon Biologics; unit may be valued at $4 billion, higher than the market cap of Biocon.
- Kunal Saraogi's 2 top trading ideas for Monday morning"The next port of call for the Nifty, is likely to be 10350. We should see some more short covering going forward."
- USFDA nod for cancer biosimilar is a big triumph: Kiran Mazumdar ShawAfter initial hiccups with the US and EU drug regulators, Shaw said this approval signifies India and her company’s capability in developin...
- Ratan Tata-backed online jewellery firm BlueStone.com targets Rs 1000-crore revenue in FY19The company is also expecting to achieve profitability around the same time. The company has clocked a turnover of Rs 250 crore in FY17.
- Axis Bank, Maruti, Sun Pharma among most active stocksSun Pharma, which was trading 2.12 per cent down at Rs 636.15 by 10.19 am, had clocked total turnover of Rs 199 crore on NSE.
- Mapping the market: Investors get allergy to pharma stocks, but lap up FMCG scripsThe domestic equity market continued its losing streak for the fourth session in a row, with the headline Sensex index shedding some 150 po...
- E-governance, green initiatives and healthcare are hot new sectors: Porinju VeliyathGoing forward many of the e-governance companies are at an inflection point. They have built some business model, infrastructure, they have...
- Om Metals has 70-80% upside potential: Sandip SabharwalThere are some companies, which should have changed their names long-time back but they just do not do it, says Sabharwal.
- Biocon can be looked at from a buying perspective: Kunal Saraogi, Technical AnalystBiocon as consolidated quite well and is now beginning to edge up.
- Market for biosimilars is very large in emerging markets: Kiran Mazumdar ShawIn an interview with ET Now, Kiran Mazumdar Shaw, Chairperson & Managing Director, Biocon, talks about the biosimilars market.
- Bicon stock can be a really good performer: Pankaj Pandey, ICICI DirectOver the last few days, the developments have been quite positive in Biocon.
- Pfizer deal shot in arm for BioconAs per the deal, Biocon will conduct clinical development and regulatory filings while Pfizer will get the exclusive rights to market these...
- Go long on NTPC, Biocon: Sandeep WagleSince the trend is so strong, the chances are that we will make a new high before we have a substantial fall.
- Biocon launches stand alone cardiology divisionBiotech major, Biocon, has decided to split its cardio-diabetes group by launching a stand alone cardiology division.
Load More
